Brief: Aptose Presents Highlights From Clinical Update
10/06/2023 17:02
June 10 (Reuters) - Aptose Biosciences Inc APS.TO :
* APTOSE PRESENTS HIGHLIGHTS FROM CLINICAL UPDATE
* COMPLETED SUCCESSFUL TYPE B EOP1 MEETING WITH US FDA
Source text for Eikon: ID:nGNX2BbTxV
Further company coverage: APS.TO
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting